Results 21 to 30 of about 132,663 (245)

Timing of Early Salvage Therapy for Patients With Biochemical Relapse of Prostate Carcinoma

Oncology Reviews, 2023
Between 25% and 33% of patients after radical prostatectomy experience a relapse of the disease. The risk of relapse increases in patients with risk factors up to 50%–80%.
Soňa Argalácsová, Michal Vočka, Otakar Čapoun, Lukáš Lambert   +3 more
doaj   +1 more source

Assessment of the value of adjuvant radiotherapy for treatment of gastric adenocarcinoma based on pattern of post-surgical progression

World Journal of Surgical Oncology, 2021
Purpose To assess the value of adjuvant radiotherapy for treatment of gastric adenocarcinoma and to investigate subgroups of patients suitable for adjuvant radiotherapy.
Peng Wang, Haihua Zhou, Gaohua Han, Qingtao Ni, Shengbin Dai, Junxing Huang, Chunlei Dai, Lei Yu   +7 more
doaj   +1 more source

An evaluation of treatments and survival rates for pancreatic adenocarcinoma through survival analysis with inverse probability of treatment weighting: a population-based study

Journal of Pancreatology, 2021
. Objective:. This study conducted inverse probability of treatment weighting (IPTW) survival analysis to examine survival in pancreatic adenocarcinoma patients. Methods:.
Suzhen Wang, Chen Wang, Fuyan Shi, Enxue Tao, Gaopei Zhu, Juan Li, Jianing Feng, Xiaoxuan Wang, Jing Guo, Qingfeng Zheng, Bo Zhang   +10 more
doaj   +1 more source

Adjuvant chemotherapy, not radiotherapy, prolongs survival for node-negative non–small cell lung cancer with positive surgical marginsCentral MessagePerspective

JTCVS Open, 2023
Objective: The study objective was to determine differences in survival depending on adjuvant therapy type, timing, and sequence in node-negative disease with positive margins after non–small cell lung cancer resection.
Arman Ashrafi, BA, Jeremy Yu, MS, Alexander T. Kim, BA, Jason C. Ye, MD, Elizabeth A. David, MD, Sean C. Wightman, MD, Scott M. Atay, MD, Takashi Harano, MD, Anthony W. Kim, MD, MS   +8 more
doaj  

The Impact of Adjuvant Radiotherapy on Clinical Performance Status in Patients With Grade II Spinal Cord Astrocytoma – A Nationwide Analysis by the Neurospinal Society of Japan [PDF]

Neurospine, 2023
Objective The impact of adjuvant radiotherapy on overall survival (OS) and progression-free survival (PFS) of patients with grade II spinal cord astrocytomas remains controversial.
Ryo Kanematsu, Masaki Mizuno, Tomoo Inoue, Toshiyuki Takahashi, Toshiki Endo, Seiji Shigekawa, Jun Muto, Daisuke Umebayashi, Takafumi Mitsuhara, Kazutoshi Hida, Junya Hanakita,   +11 more
doaj   +1 more source

Adjuvant radiotherapy for rectal cancer

British Journal of Surgery, 2006
A hotly debated ...
K T Moesta, F Köckerling
openaire   +3 more sources

Analysis of radiotherapy impact on survival in resected stage I/II pancreatic cancer patients: a population-based study

BMC Cancer, 2021
Background The application of radiotherapy (RT) in pancreatic cancer remains controversial. Aim The aim of the study was to evaluate the efficacy of radiotherapy (neoadjuvant and adjuvant radiotherapy) for resectable I/II pancreatic cancer.
Dong Han, Fei Gao, Jin Long Liu, Hao Wang, Qi Fu, Guo Wang Yang   +5 more
doaj   +1 more source

Overall Survival Benefit in Rectal Cancer After Neoadjuvant Radiotherapy and Adjuvant Chemotherapy: A Propensity-Matched Population-Based Study

Frontiers in Oncology, 2020
BackgroundIt is well known that neoadjuvant radiotherapy could reduce local recurrence followed by surgical resection. However, evidence about oncologic efficacy of radiotherapy and survival benefit of adjuvant chemotherapy after neoadjuvant radiotherapy
Zhiju Chen, Shaowei Li, Yehong Wang, Zhiming Fu, Ning Liu, Hao Wang, Xin Liu   +6 more
doaj   +1 more source

Hypofractionation in adjuvant breast radiotherapy

The Breast, 2010
Altered fractionation for whole breast irradiation has been extensively studied over the past 20 years, with recent updated publications from several landmark randomized trials. In this review, the radiobiological principles underlying altered fractionation schedules are reviewed, and outcomes, including local control, acute and chronic toxicities from
Bruce G. Haffty, Atif J. Khan
openaire   +3 more sources

Surgery, adjuvant immunotherapy plus chemotherapy and radiotherapy for primary malignant melanoma of the parotid gland (PGMM): A case report

Open Life Sciences, 2023
Primary malignant melanoma of the parotid gland (PGMM) is extremely rare, with a poor prognosis. Surgery is the main treatment option followed by adjuvant treatments such as radiotherapy, but which adjuvant treatment to be optimal is still controversial.
Zhao Qiang, Li Zhi-Ke, Gui Yan, Ma Dai-Yuan, Du Guo-Bo, Li Xian-Fu   +5 more
doaj   +1 more source